Search research articles
Contact Us
Filters
Showing results (31-40 of 206) with videos related to
Page
of 21
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
July 6, 2023
Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer
Paola Grandi, Andrea Darilek, Anay Moscu, et al.
European Urology
|
May 7, 2019
Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol 2019;76:4-6
Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
European Urology
|
March 6, 2019
Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer
Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
European Urology
|
January 26, 2024
The Elusive Horizon: Biomarkers in Urothelial Carcinoma
Joshua A Linscott, Joshua J Meeks, Lars Dyrskjøt, et al.
Histopathology
|
December 12, 2025
Recent advances in liquid biopsy for genitourinary cancers: A narrative review
Christian F Harrs, Sricharan Pusala, Liang Cheng, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
February 3, 2017
Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients
Roger Li, John Amrhein, Zvi Cohen, et al.
European Urology
|
February 25, 2026
Less Is More? How Much Bacillus Calmette-Guérin (BCG) Is Enough for BCG-naïve High-risk Non-muscle invasive Bladder Cancer?
David J Nusbaum, Roger Li, Charles C Peyton, et al.
JAMA Network Open
|
April 16, 2026
Clinical Outcomes in Bacillus Calmette-Guérin-Exposed Non-Muscle-Invasive Bladder Cancer
Maria Giatsoglou, Dimitrios Chatzistavrou, Joan Mazzarelli Sopczynski, et al.
Clinical Genitourinary Cancer
|
October 3, 2017
Characterization of Glomus Tumors of the Kidney
Roger Li, Firas G Petros, Charles J Davis, et al.
Communications Biology
|
December 18, 2020
Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
Qianxing Mo, Roger Li, Dennis O Adeegbe, et al.
Page
of 21
Search research articles
Search
Showing results (31-40 of 206) with videos related to
Sort By:
Page
of 21
Methods in Molecular Biology (Clifton, N.J.)
|
July 6, 2023
Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer
Paola Grandi, Andrea Darilek, Anay Moscu, et al.
European Urology
|
May 7, 2019
Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol 2019;76:4-6
Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
European Urology
|
March 6, 2019
Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer
Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
European Urology
|
January 26, 2024
The Elusive Horizon: Biomarkers in Urothelial Carcinoma
Joshua A Linscott, Joshua J Meeks, Lars Dyrskjøt, et al.
Histopathology
|
December 12, 2025
Recent advances in liquid biopsy for genitourinary cancers: A narrative review
Christian F Harrs, Sricharan Pusala, Liang Cheng, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
February 3, 2017
Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients
Roger Li, John Amrhein, Zvi Cohen, et al.
European Urology
|
February 25, 2026
Less Is More? How Much Bacillus Calmette-Guérin (BCG) Is Enough for BCG-naïve High-risk Non-muscle invasive Bladder Cancer?
David J Nusbaum, Roger Li, Charles C Peyton, et al.
JAMA Network Open
|
April 16, 2026
Clinical Outcomes in Bacillus Calmette-Guérin-Exposed Non-Muscle-Invasive Bladder Cancer
Maria Giatsoglou, Dimitrios Chatzistavrou, Joan Mazzarelli Sopczynski, et al.
Clinical Genitourinary Cancer
|
October 3, 2017
Characterization of Glomus Tumors of the Kidney
Roger Li, Firas G Petros, Charles J Davis, et al.
Communications Biology
|
December 18, 2020
Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
Qianxing Mo, Roger Li, Dennis O Adeegbe, et al.
Page
of 21